You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute Lymphoblastic Leukemia (ALL) Philadelphia chromosome positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

No longer available
  • Acute Lymphoblastic Leukemia (ALL)
  • (no location specified)
Aug 5, 2022

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Tianjin (Olverembatinib, Venetoclax, prednisone)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Oct 21, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed
Has Results
  • Acute Undifferentiated Leukemia
  • +13 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Apr 5, 2022

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Adult Philadelphia Chromosome-Positive Acute Lymphoblastic

Recruiting
  • Acute Lymphoblastic Leukemia
  • Dasatinib and blinatumomab
  • Bari, Italy
  • +16 more
Oct 10, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia Trial in

Not yet recruiting
  • Lymphoblastic Leukemia, Acute, Childhood
  • +3 more
  • Olverembatinib, APG-2575, Dexamethasone
  • Hefei, Anhui, China
  • +3 more
Aug 8, 2022

Philadelphia Positive Acute Lymphoblastic Leukemia Trial in Germany (Dasatinib)

Completed
  • Philadelphia Positive Acute Lymphoblastic Leukemia
  • Stuttgart, Baden-Württemberg, Germany
  • +21 more
Jan 10, 2022

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

ALL Trial in Spain (Prednisone, Vincristine, Daunorubicin)

Active, not recruiting
  • ALL
  • Badalona, Spain
  • +9 more
Feb 17, 2022

Acute Leukemia Trial in Tianjin (Flumatinib, Imatinib)

Recruiting
  • Acute Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2021

Iclusig PMS in CML or Ph+ALL Patients

Recruiting
  • Chronic Myeloid Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Busan, Korea, Republic of
    Kosin University Gaspel Hospital
Sep 16, 2021

Ph+ ALL Trial in China (Olverembatinib, Imatinib)

Recruiting
  • Ph+ ALL
  • Chongqing, Chongqing, China
  • +8 more
Sep 22, 2023

Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome-Positive
  • Blinatumomab
  • +3 more
  • New York, New York
  • +1 more
Nov 10, 2022

Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 28, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

Completed
  • Acute,Leukemia, Lymphoid
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 2, 2022

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL Trial in Italy (Ponatinib

Recruiting
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • +2 more
  • Ponatinib + Blinatumomab
  • Chemotherapy + Imatinib
  • Ascoli Piceno, Italy
  • +14 more
Jan 3, 2022

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),

Recruiting
  • Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
  • +2 more
  • Phoenix, Arizona
  • +69 more
Aug 23, 2022

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022